BONE BIOLOGICS CORPORATION
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.6M | $6.7M |
| FY2022 | — | $5.9M | — |
| FY2023 | — | $2.9M | — |
| FY2024 | — | $3.5M | — |
| FY2025 | — | $5.4M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.6M | $6.7M |
| FY2022 | — | $5.9M | — |
| FY2023 | — | $2.9M | — |
| FY2024 | — | $3.5M | — |
| FY2025 | — | $5.4M | — |